BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9151165)

  • 41. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer.
    Hanasono MM; Kunda LD; Segall GM; Ku GH; Terris DJ
    Laryngoscope; 1999 Jun; 109(6):880-5. PubMed ID: 10369275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site.
    Cianchetti M; Mancuso AA; Amdur RJ; Werning JW; Kirwan J; Morris CG; Mendenhall WM
    Laryngoscope; 2009 Dec; 119(12):2348-54. PubMed ID: 19718744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor.
    Zhao K; Luo XM; Zhou SH; Liu JH; Yan SX; Lu ZJ; Yang SY; Lin LL; Dong MJ
    Cancer Biother Radiopharm; 2012 Dec; 27(10):685-93. PubMed ID: 22834634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor.
    Fogarty GB; Peters LJ; Stewart J; Scott C; Rischin D; Hicks RJ
    Head Neck; 2003 Feb; 25(2):138-45. PubMed ID: 12509797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
    Yao M; Smith RB; Graham MM; Hoffman HT; Tan H; Funk GF; Graham SM; Chang K; Dornfeld KJ; Menda Y; Buatti JM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):991-9. PubMed ID: 16099601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site.
    Sève P; Billotey C; Broussolle C; Dumontet C; Mackey JR
    Cancer; 2007 Jan; 109(2):292-9. PubMed ID: 17167760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metastatic squamous cell carcinoma of the gingiva appearing as a solitary branchial cyst carcinoma: diagnostic role of PET/CT.
    Zhang XX; Zhao K; Zhou SH; Wang QY; Liu JH; Lu ZJ
    Int J Clin Exp Pathol; 2014; 7(10):7059-63. PubMed ID: 25400796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor].
    Schipper JH; Schrader M; Arweiler D; Müller S; Sciuk J
    HNO; 1996 May; 44(5):254-7. PubMed ID: 8707630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is PET superior to MRI in the pretherapeutic evaluation of head and neck squamous cell carcinoma?
    Minovi A; Hertel A; Ural A; Hofmann E; Draf W; Bockmuehl U
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(6):324-8. PubMed ID: 18187997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy.
    Chaiken L; Rege S; Hoh C; Choi Y; Jabour B; Juillard G; Hawkins R; Parker R
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):455-64. PubMed ID: 8407422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer.
    Kitagawa Y; Nishizawa S; Sano K; Sadato N; Maruta Y; Ogasawara T; Nakamura M; Yonekura Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Feb; 93(2):202-7. PubMed ID: 11862212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients.
    Paulus P; Sambon A; Vivegnis D; Hustinx R; Moreau P; Collignon J; Deneufbourg JM; Rigo P
    Laryngoscope; 1998 Oct; 108(10):1578-83. PubMed ID: 9778305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
    Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M
    Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Deron PB; Bonte KM; Vermeersch HF; Van de Wiele C
    Cancer Biother Radiopharm; 2011 Jun; 26(3):331-4. PubMed ID: 21711095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck.
    Schmid DT; Stoeckli SJ; Bandhauer F; Huguenin P; Schmid S; von Schulthess GK; Goerres GW
    Laryngoscope; 2003 May; 113(5):888-91. PubMed ID: 12792328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The current status of positron-emission tomography scanning in the evaluation and follow-up of patients with head and neck cancer.
    Kutler DI; Wong RJ; Schoder H; Kraus DH
    Curr Opin Otolaryngol Head Neck Surg; 2006 Apr; 14(2):73-81. PubMed ID: 16552262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Detection of primary carcinoma by positron emission tomography in an unknown primary tumor with cervical metastasis: a case report].
    Cakli H; Altin F; Ak I; Gürbüz MK; Ozüdoğru E
    Kulak Burun Bogaz Ihtis Derg; 2005; 14(1-2):39-43. PubMed ID: 16227723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Occult squamous cell carcinoma of the uvula detected by F-18 FDG PET/CT in a case of carcinoma of unknown primary in the head and neck.
    Salem S; Patel NH; Barwick T; Al-Nahhas A; Howard DJ; Zerizer I; Win Z
    Clin Nucl Med; 2010 Oct; 35(10):800-1. PubMed ID: 20838291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Staging of head and neck squamous cell cancer with extended-field FDG-PET.
    Schwartz DL; Rajendran J; Yueh B; Coltrera M; Anzai Y; Krohn K; Eary J
    Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1173-8. PubMed ID: 14623746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.